Resource Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$697K Sell
5,145
-703
-12% -$83K 0.07% 86
2021
Q3
$631K Buy
5,848
+242
+4% +$27.7K 0.07% 89
2021
Q2
$631K Sell
5,606
-2,279
-29% -$257K 0.07% 91
2021
Q1
$853K Buy
7,885
+1,243
+19% +$133K 0.1% 73
2020
Q4
$712K Buy
6,642
+564
+9% +$54.2K 0.1% 74
2020
Q3
$532K Buy
6,078
+444
+8% +$41.8K 0.09% 85
2020
Q2
$553K Sell
5,634
-299
-5% -$26.3K 0.1% 69
2020
Q1
$452K Buy
5,933
+960
+19% +$81.8K 0.1% 72
2019
Q4
$440K Sell
4,973
-939
-16% -$78K 0.07% 91
2019
Q3
$447K Buy
5,912
+622
+12% +$42.6K 0.08% 84
2019
Q2
$385K Sell
5,290
-13
-0.2% -$1.02K 0.07% 98
2019
Q1
$427K Buy
5,303
+661
+14% +$54.1K 0.08% 89
2018
Q4
$428K Sell
4,642
-166
-3% -$14.6K 0.09% 79
2018
Q3
$455K Buy
4,808
+60
+1% +$5.69K 0.08% 78
2018
Q2
$439K Buy
4,748
+123
+3% +$12K 0.09% 75
2018
Q1
$438K Buy
4,625
+15
+0.3% +$1.65K 0.09% 73
2017
Q4
$516K Buy
+4,610
New +$434K 0.11% 74

Other funds holding ABBV

Resource Management's ABBV Position: Q4 2021 in Review

Resource Management reduced its AbbVie (ABBV) stake by 12% in Q4 2021, selling an estimated $83K and leaving 5,145 shares worth $697K. The position accounts for 0.07% of the portfolio, ranked #86.

Resource Management first reported a position in ABBV in Q4 2017 and has held it in 17 quarters since. The position peaked at $853K in Q1 2021. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • Resource Management held 5,145 shares of AbbVie worth $697K as of Q4 2021.
  • Resource Management sold 703 AbbVie shares in Q4 2021, an estimated $83K.
  • AbbVie made up 0.07% of Resource Management's portfolio in Q4 2021, its #86 holding.
  • Resource Management first reported a position in AbbVie in Q4 2017 and has held it in 17 quarters since.
  • Resource Management's AbbVie position peaked at $853K in Q1 2021.
  • 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Resource Management's 13F filing for Q4 2021, filed 14 Feb 2022.